Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer

By sjmartinez • July 14, 2024

Preston MA, Ebrahimi R, Hong A, Bobbili P, Desai R, Duh MS, Gandhi R, Hanson S, Dufour R, Morgans AK. Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer. Urol Oncol. 2024 Jul 12:S1078-1439(24)00499-X. doi: 10.1016/j.urolonc.2024.05.026. Epub ahead of print. PMID: 39003108.

Tags: Androgen deprivation therapy, Cardiology/Epi, cardiovascular risk, Continuous ADT, Endocrine or metabolic risk, Intermittent ADT, Nonmetastatic prostate cancer, Publications, Veterans Administration

Improved hemodynamic performance and reduced paravalvular regurgitation with the SAPIEN 3 Ultra RESILIA valve: a propensity-matched single-center TAVR study

Krishnareddigari M, Joodi G, Zinoviev RI, Yarra S, Aksoy O. Improved hemodynamic performance and reduced paravalvular regurgitation with the SAPIEN 3 Ultra RESILIA valve: a[...]

Effect of Omega-3 fatty acids, fibrates and PCSK9 inhibitors on atherosclerotic plaque burden, composition and stability: Insights from imaging

Roman S, Budoff MJ. Effect of Omega-3 fatty acids, fibrates and PCSK9 inhibitors on atherosclerotic plaque burden, composition and stability: Insights from imaging. Pharmacol Ther.[...]

Optimization of Image Quality for Quantitative Multicontrast Atherosclerosis Characterization (qMATCH): Comparison between Transverse and Coronal Acquisitions

Hsu YC, Lu M, Llanes A, Keushkerian MJ, Nguyen KL, Johnson K, Altbach MI, Morris HD, DeMarco JK, Deshpande V, Mitsouras D, Saloner D, McNally[...]